Zhejiang Qizheng Pharmaceutical Co., Ltd. announced it will raise CNY 20,000,000 in an equity round of funding on April 26, 2023. The transaction included participation from returning investor Zhejiang Ausun Pharmaceutical Co., Ltd. After the paid-in registered capital and capital increase are completed, the registered capital of company will increase to CNY 120,000,000 and the capital reserve will increase to CNY 210,318,752.57. The transaction was approved by the board of directors in its18th meeting of the third board of directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.66 CNY | -3.21% | -3.98% | -26.87% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.87% | 814M | |
+54.07% | 809B | |
+38.95% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.21% | 238B | |
-0.45% | 221B | |
+14.58% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- 603229 Stock
- News Zhejiang Ausun Pharmaceutical Co., Ltd.
- Zhejiang Qizheng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Ausun Pharmaceutical Co., Ltd.